HR Execs on the Move


 
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.my01.io
  • 400 Boul de Maisonneuve Ouest Suite 700
    Montréal, QC CAN H3A 1L4
  • Phone: 855.799.6901

Executives

Name Title Contact Details
Jay Merkel
Chief Commercial Officer Profile

Similar Companies

Avedro

Avedro is a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.

Cytori

Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.

Neuroptix Corporation

Neuroptix Corporation is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroBioLogics

MicroBioLogics is a Saint Cloud, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

US HIFU

US HIFU is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.